Press Releases on August 5, 2020 - EIN Presswire - Press Release Distribution Service

Published on August 5, 2020 - 11:00 GMT

Kamada to Announce Second Quarter Ended June 30, 2020 Financial Results and Host Conference Call on August 12, 2020

REHOVOT, Israel, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), plasma-derived biopharmaceutical company, today announced that it will release financial results for the second quarter ended June 30, 2020, prior to the open of the …

Distribution channels:

Published on August 5, 2020 - 11:00 GMT

GasLog Partners LP Announces Chief Executive Officer and Directors Transition

Piraeus, Greece, Aug. 05, 2020 (GLOBE NEWSWIRE) -- GasLog Ltd. ("GasLog") (NYSE: GLOG) and GasLog Partners LP ("GasLog Partners" or the "Partnership" and together with GasLog, the “Group”) (NYSE: GLOP) announced today senior …

Distribution channels: Companies, Media, Advertising & PR ...

Published on August 5, 2020 - 11:00 GMT

United Fire Group, Inc. Reports Second Quarter 2020 Results

CEDAR RAPIDS, Iowa, Aug. 05, 2020 (GLOBE NEWSWIRE) -- United Fire Group, Inc. (Nasdaq: UFCS), Consolidated Financial Results - Highlights(1): Three Months Ended June 30, 2020 Six Months Ended June 30, 2020 Net income per diluted share $ 0.24 Net …

Distribution channels: Business & Economy, Insurance Industry ...

Published on August 5, 2020 - 11:00 GMT

Calibre Mining Recommences Blasting and Mining Activities at its Jabali Underground Mine, Part of the Libertad Complex

VANCOUVER, British Columbia, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Calibre Mining Corp. (TSX: CXB; OTCQX: CXBMF) (the “Company” or “Calibre”) is pleased to announce that blasting and mining activities have recommenced at its Jabali underground mine, part of …

Distribution channels:

Published on August 5, 2020 - 11:00 GMT

Cerecor to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference

ROCKVILLE, Md., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a leading biopharmaceutical company focused on the development and commercialization of treatments for rare pediatric and orphan diseases, today announced that Michael F. Cola, …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on August 5, 2020 - 11:00 GMT

BeiGene Announces Data on Tislelizumab and Pamiparib to Be Presented at the 2020 European Society for Medical Oncology (ESMO) ...

CAMBRIDGE, Mass. and BEIJING, China, Aug. 05, 2020 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on August 5, 2020 - 11:00 GMT

Altimmune to Announce Second Quarter 2020 Financial Results on August 12

GAITHERSBURG, Md., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report financial results for the three and six months ended June 30, 2020 and its business outlook …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on August 5, 2020 - 11:00 GMT

Broadwind Announces Second Quarter 2020 Results

CICERO, Ill., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Broadwind (NASDAQ: BWEN), a diversified precision manufacturer of specialized components and solutions serving global markets, today announced results for the second quarter 2020. 2Q20 HIGHLIGHTS Total …

Distribution channels: Business & Economy, Consumer Goods ...

Published on August 5, 2020 - 11:00 GMT

CB2 Insights Technology Platform Selected by Dharma Pharmaceuticals to Study Real-World Health Outcomes

Dharma will license the Company’s proprietary technology platform “Sail” to use at the point of care within Dharma dispensaries and its network of support centers in Virginia. Sail will be used to monitor, track and generate insights on patient health …

Distribution channels:

Published on August 5, 2020 - 11:00 GMT

Medtronic Announces Comprehensive U.S. Launch of New InterStim™ Micro Neurostimulator

First Patient Receives New Sacral Neuromodulation Device Implant at Cleveland Clinic DUBLIN, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that its recently FDA-approved InterStim™ …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on August 5, 2020 - 11:00 GMT

i3 Interactive and the Incredible Dan Bilzerian Effect

TORONTO, Aug. 05, 2020 (GLOBE NEWSWIRE) -- i3 Interactive Inc. (“i3 Interactive” or the “Company”) (CSE: BETS)(FRA: F0O3) is pleased to report that Dan Bilzerian’s (“Dan” or “Mr. Bilzerian”) first marketing initiative this past Friday, July 31st, 2020, …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on August 5, 2020 - 11:00 GMT

Harvard Bioscience Announces Second Quarter 2020 Financial Results

Operating Income up sequentially and year-over-year on both GAAP and adjusted basis Cost reduction programs offset expected declines in Academic markets Net Debt reduced by $2.2 million in Q2 HOLLISTON, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Harvard …

Distribution channels:

Published on August 5, 2020 - 11:00 GMT

Astec Reports Second Quarter 2020 Results

Second Quarter 2020 Highlights (all comparisons are made to the prior year second quarter): Net Sales decreased 13.0% to $265.3M; Adjusted Net Sales decreased just 6.8% due to $20.0M included in 2019 sale of a wood pellet plant Gross margin of 22.5% …

Distribution channels: Automotive Industry, Business & Economy ...

Published on August 5, 2020 - 11:00 GMT

EyePoint Pharmaceuticals Reports Second Quarter 2020 Financial Results and Highlights Recent Corporate Developments

- Total revenues of $4.1 million and net product revenues of $3.7 million impacted by COVID-19 pandemic - - U.S. commercial alliance with ImprimisRx to expand reach of DEXYCU® - - Jay S. Duker, M.D., world-renowned retinal specialist, joins as Chief …

Distribution channels:

Published on August 5, 2020 - 11:00 GMT

Stella-Jones Reports Record Second Quarter 2020 Results

EBITDA increased 28% to a record $120 million Net income rose to $69 million or $1.02 per share Net debt to trailing 12-month EBITDA decreased to 1.9x Updated 2020 outlook to reflect strong quarterly performance Announced a Normal Course Issuer Bid …

Distribution channels: Business & Economy, Consumer Goods ...

Published on August 5, 2020 - 11:00 GMT

Constellation Pharmaceuticals Announces Second-Quarter 2020 Financial Results, Provides Regulatory Update

Constellation has aligned with the FDA on the design of MANIFEST-2, the pivotal Phase 3 clinical trial for CPI-0610 expected to begin in 2H20 Constellation plans to explore additional indications for CPI-0610 CAMBRIDGE, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE …

Distribution channels:

Published on August 5, 2020 - 11:00 GMT

Michigan Medicine Selects Mach7’s eUnity SMARTviewer to Drive Enterprise Viewing Strategy

BURLINGTON, Vt., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Mach7 Technologies, a leading provider of data management and enterprise imaging solutions for healthcare organizations, announced today that Michigan Medicine has selected Mach7’s eUnity SMARTviewer for …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on August 5, 2020 - 11:00 GMT

Fulcrum Therapeutics to Host Second Quarter 2020 Financial Results Conference Call and Webcast on Tuesday, August 11, 2020 at 8:00 ...

CAMBRIDGE, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that its second …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on August 5, 2020 - 11:00 GMT

Surgery Partners, Inc. Announces Second Quarter 2020 Results

BRENTWOOD, Tenn., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the second quarter …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on August 5, 2020 - 11:00 GMT

Axsome Therapeutics Receives FDA Breakthrough Therapy Designation for AXS-12 for the Treatment of Narcolepsy

Designation offers potential for expedited development and review FDA Orphan Drug Designation previously granted to Axsome for AXS-12 in narcolepsy Third FDA Breakthrough Therapy designation received by Axsome NEW YORK, Aug. 05, 2020 (GLOBE NEWSWIRE) -- …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...